Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence ...

The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb ...

Drastic action is considered essential, but this is part of a wider strategy that represents a looming calamity for Stormont ...

Britain will study whether the use of Eli Lilly's weight loss drug can get people back into work and help tackle the high ...

A new study published Thursday found that groundbreaking weight loss and diabetes medications also combat opioid-use disorder and alcohol misuse disorder. This is the second study this fall to suggest ...

Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use ...